Pediatric Exploratory Research Study of EGCG Use and Safety (PERSEUS)
Pediatric Exploratory Research Study of EGCG Use and Safety (PERSEUS)
NCT ID: NCT03624556 Phase: NA Status: COMPLETED Enrollment: 76 Completion: 2020-11-30
Conditions
Down Syndrome, Fragile X Syndrome
Interventions
EGCG FontUp, Placebo FontUp
Summary
To evaluate safety and tolerability of epigallocatechin gallate (EGCG) in children from 6 to 12 years old with Intellectual Developmental Disorders (IDD) (Down syndrome or Fragile X syndrome).
Primary Outcome
Safety Outcome Measure : Adverse Events